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Background: Insulin receptor substrate (IRS)-1 is associated with tumorigenesis; its levels are elevated in several
human cancers. IRS-1 protein binds to several oncogene proteins. Oxidative stress and reactive oxygen species
(ROS) are involved in the initiation and progression of cancers. Cancer cells produce greater levels of ROS than
normal cells do because of increased metabolic stresses. However, excessive production of ROS kills cancer cells.
Autophagy usually serves as a survival mechanism in response to stress conditions, but excessive induction of
autophagy results in cell death. In addition to inducing necrosis and apoptosis, ROS induces autophagic cell death.
ROS inactivates IRS-1 mediated signaling and reduces intracellular IRS-1 concentrations. Thus, there is a complex
relationship between IRS-1, ROS, autophagy, and cancer. It is not fully understood how cancer cells grow rapidly
and survive in the presence of high ROS levels.
Methods and results: In this study, we established mouse NIH/3T3 cells that overexpressed IRS-1, so mimicking
cancers with increased IRS-1 expression levels; we found that the IRS-1 overexpressing cells grow more rapidly than
control cells do. Treatment of cells with glucose oxidase (GO) provided a continuous source of ROS; low dosages of
GO promoted cell growth, while high doses induced cell death. Evidence for GO induced autophagy includes
increased levels of isoform B-II microtubule-associated protein 1 light chain 3 (LC3), aggregation of green
fluorescence protein-tagged LC3, and increased numbers of autophagic vacuoles in cells. Overexpression of IRS-1
resulted in inhibition of basal autophagy, and reduced oxidative stress-induced autophagy and cell death. ROS
decreased the mammalian target of rapamycin (mTOR)/p70 ribosomal protein S6 kinase signaling, while
overexpression of IRS-1 attenuated this inhibition. Knockdown of autophagy-related gene 5 inhibited basal
autophagy and diminished oxidative stress-induced autophagy and cell death.
Conclusion: Our results suggest that overexpression of IRS-1 promotes cells growth, inhibits basal autophagy,
reduces oxidative stress-induced autophagy, and diminishes oxidative stress-mediated autophagy-dependent cell
death. ROS-mediated autophagy may occur via inhibition of IRS-1/phosphatidylinositol 3-kinase/mTOR signaling.
Our data afford a plausible explanation for IRS-1 involvement in tumor initiation and progression.
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The insulin receptor substrate (IRS) proteins are a family
of cytoplasmic adaptor proteins recognized for their role
in insulin signaling. IRS-1 was the first of these to be
identified as a 185 kDa protein that is detectable by
immunoblot analysis in response to insulin stimulation
[1]. IRS-1 shows no intrinsic enzymatic activity and con-
tributes to signaling through its role as an adaptor for
the organization of signaling complexes [2]. Upon acti-
vation by its upstream stimulators, IRS-1 generates bind-
ing sites for downstream effectors in its C-terminal
region [3]. The main IRS-1 downstream signaling path-
ways include type I phosphatidylinositol 3-kinase
(PI3K)/Akt (PKB: protein kinase B), mammalian target
of rapamycin (mTOR), and mitogen activated protein
kinase (MAPK)/extracellular signal-regulated kinase
(ERK). Many of these effector pathways have been impli-
cated in cell growth, proliferation, tumorigenesis, and
cancer progression [4]. IRS-1 exhibits increased expres-
sion in hepatocellular, pancreatic, prostatic, breast, and
ovarian cancers [5-10]. The activation of both MAPK
and PI3K signaling pathways has been implicated in the
stimulation of proliferation by IRS-1 [11].
Organisms living in an aerobic environment require
oxygen for their vital cellular processes. Cells generate
partially reduced forms of oxygen, collectively referred
to as “reactive oxygen species” (ROS), during respiration
and enzymatic processes. The production of ROS in ex-
cess of the organisms endogenous cellular capacity for
detoxification and utilization results in a non-
homeostatic state referred to as “oxidative stress” [12].
Low levels of ROS can promote cell proliferation but
high levels induce cell death [13]. ROS and oxidative
stress have long been associated with cancer. Cancer
cells produce higher levels of ROS than normal cells do,
due to increased metabolic stresses [14]. Additionally,
ROS is involved in the initiation and progression of can-
cers, damage to DNA, genetic instability, cellular injury,
and cell death [15-17]. Hence, the association of ROS
with cancer cells is complex; it is important to under-
stand how cancer cells can grow rapidly and survive
while exposed to high levels of ROS.
Modes of cell death are usually defined by morpho-
logical criteria, and these include apoptosis, necrosis,
autophagic cell death, mitotic catastrophe, anoikis, exci-
totoxicity, Wallerian degeneration, and cornification
[18]. Oxidative stress induces apoptosis, and the molecu-
lar mechanisms involved have been well delineated [19].
Oxidative stress also induces necrotic cell death [20-22],
and ROS was recently reported to induce autophagy
[23-26] and apoptosis-independent autophagic cell death
[27]. One molecular mechanism for oxidative stress-
induced autophagy involves the activation of AMP-
activated protein kinase (AMPK) [28]. AMPK is anupstream regulator of mTOR, the core negative regula-
tor of autophagy [29], and it negatively regulates mTOR
either by direct inhibition [30,31] or by activating tuber-
ous sclerosis complex proteins, upstream negative regu-
lators of mTOR [32]. Oxidative stress activates AMPK
by stimulation of ataxia-telangiectasia mutated protein
(ATM), an upstream activator of AMPK [33]. Taken to-
gether, oxidative stress can induce autophagy via AMPK-
mediated inhibition of mTOR. Further, oxidative stress
inhibits IRS-1/PI3K/Akt signaling via AMPK-dependent
phosphorylation of IRS-1 at Ser-794, leading to dissoci-
ation of IRS-1 from its upstream membrane growth fac-
tor receptors [34]. Oxidative stress also reduces
endogenous IRS-1 levels [34,35]. Because IRS-1/PI3K/
Akt signaling can activate mTOR activity [31,36], which
is well known to inhibit autophagy [31,36], it is possible
that oxidative stress induces autophagy via AMPK-
mediated inhibition of IRS-1/PI3K/Akt/mTOR signaling.
By contrast, Akt inhibits AMPK by interrupting with its
activation by liver kinase B (LKB)-1 [37]. Hence, it is
possible that IRS-1 negatively regulates autophagy
through Akt, to inhibit AMPK or to increase mTOR ac-
tivity. However, although this appears to be a reasonable
hypothesis, there have been no reports supporting the
notion that increased levels of IRS-1 inhibit autophagy,
until now.
Inevitably, ROS concentrations increase during rapid
cell growth, and the increased ROS levels may kill the
cells. ROS induces autophagy, which contributes to oxi-
dative stress-mediated autophagic cell death [27], while
both ROS and IRS-1 signaling can influence each other.
Thus, we propose that IRS-1 plays an important role in
oxidative stress-mediated autophagic cell death. In this
study, we demonstrate that overexpression of IRS-1 pro-
motes cells growth, inhibits basal autophagy, reduces
oxidative stress-induced autophagy, and diminishes oxi-
dative stress-mediated autophagy-dependent cell death.
In addition, we provide evidence to support the notion
that oxidative stress-induced autophagy may occur via




Human IRS-1 (NM_005544) cDNA was cloned from a
cDNA library and subcloned into pMXs retroviral vector
(Cell Biolabs). The retroviral packaging cell line,
Platinum-E cell line (Cell Biolabs), was then transfected
with control pMXs vector or that containing human
IRS-1 cDNA, using FuGENE 6 transfection reagent
(Roche Applied Science). Retroviruses were harvested
and used to infect NIH/3T3 cells using polybrene
(Sigma-Aldrich). Cells with integrated genes were
selected using 4 μg/ml puromycin (Sigma-Aldrich).
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fied Eagle medium (DMEM) supplemented with 10 %
fetal bovine serum (FBS), 100 μg/ml streptomycin, 100
U/ml penicillin, and 1 μg/ml puromycin at 37 °C, under
5 % CO2.
Cells with knockdown of autophagy-related gene
(ATG)-5 or overexpression of green fluorescence protein
(GFP)-microtubule-associated protein-1 light chain 3
(LC3):
Lentiviral vector (pLKO.1) with an insert for short
hairpin RNA (shRNA) targeting mouse ATG-5 was pro-
vided by the National RNAi Core Facility Platform in
Academia Sinica, Taiwan. The accession number of the
mouse ATG-5 gene is NM_053069. The control lenti-
virus and the virus to produce mouse ATG-5 targeting
shRNA were made by the RNAi core lab at the Clinical
Research Center, National Cheng Kung University Hos-
pital, Tainan, Taiwan. Lentivirus was used to infect
mouse NIH/3T3 cells using polybrene (Sigma-Aldrich).
Cells with integrated genes were selected using 4 μg/ml
puromycin.
To establish cell lines with stable expression of GFP-
LC3, control NIH/3T3 cells and NIH/3T3 cells over-
expressing IRS-1 were transfected using GFP-LC3
plasmids gifted by Dr. Noboru Mizushima (Tokyo
Medical and Dental University, Tokyo, Japan). Follow-
ing transfection with Lipofectamine 2000 (Invitrogen)
for 48 h, positive stable clones were selected by cultur-
ing cells with G418 (400 μg/ml) for 2 weeks while
being maintained in DMEM supplemented with 10 %
FBS, 100 μg/ml streptomycin, 100 U/ml penicillin, and
200 μg/ml G418 at 37 °C, under 5 % CO2.
Detection of intracellular reactive oxygen species (ROS)
induced by glucose oxidase (GO)
To investigate the influence of chronic exposure to oxi-
dative stress on autophagy, we used a GO/glucose sys-
tem as a source of intracellular ROS. Adding GO to the
culture medium provides a continuous supply of ROS,
and the system is thus a suitable model for studying
chronic exposure of cells to ROS [38]. The amount of
intracellular ROS in the cytosolic fraction was measured
using an OxiSelect™ Intracellular ROS Assay Kit (Cell
Biolabs).
Cell viability and proliferation assay
A trypan blue dye (Invitrogen) exclusion assay was used
to examine cell viability. Cells were collected by trypsini-
zation, washed once with phosphate buffered saline
(PBS), and suspended in 0.2 % trypan blue solution.
Nonviable cells stained with a blue color due to loss of
membrane integrity; viable cells excluded the dye and
remained unstained (white). The percentage of dead cells
was calculated.Cell proliferation was measured quantitatively by add-
ing 10 % (v/v) alamarBlue (Invitrogen) to the culture
medium, according to the manufacturer’s instructions.
The reduced form of alamarBlue, an indicator of cell
proliferation, was measured using a fluorescence plate
reader (SpectralMax M5, Molecular Devices) with exci-
tation and emission wavelengths of 570 nm and 600 nm,
respectively.Flow cytometry
All cells, including floating and adherent cells, were har-
vested, washed with PBS, suspended in 1 ml of PBS, and
then fixed by adding 3 ml of 100 % ethanol that was
cooled to −20 °C in advance. Then, the cells were stored
overnight at 4 °C. The cells were washed with PBS and
stained with propidium iodide (PI)/Triton X-100 solu-
tion (0.1 % Triton X-100, 0.2 mg/ml RNase, 20 μg/μl PI
in PBS) for 3 h on ice and in darkness. DNA content
was determined by flow cytometry using a FACSCalibur
cytometer (BD Biosciences). The percentage of sub-G1
DNA was analyzed by gating on cell cycle dot blots
using Windows Multiple Document Interface software
(WinMDI) version 2.9.Western blot analysis
Cell lysates were prepared using ice-cold lysis buffer
(20 mM Tris–HCl at pH 7.5, 1 mM EDTA, 1 mM
EGTA, 150 mM NaCl, 1 % Triton X-100, 10 mM NaF,
1 mM Na3VO4, 10 mM 2-mercaptoethanol, and a prote-
ase inhibitors cocktail). The cell lysates were centrifuged
at 15,000 rpm for 20 min at 4 °C, and the supernatants
were collected for Western blot analysis. The signals of
target proteins were detected using a chemiflurorescent-
immunoblotting detection reagent (GE HealthCare) and
a luminescent image analyzer LAS-1000 (FUJI FILM).
Densitometry analysis of Western blots was conducted
using Multi Gauge 2.11 software (FUJI FILM), and the
expression level of each protein, relative to that of actin,
was determined. The following antibodies including
anti-p70 ribosomal protein S6 kinase, anti-S6 ribosomal
protein, anti-Akt, anti-p44/42 MAPK, anti-glycogen syn-
thase kinase 3 beta, anti-phospho-p70 ribosomal protein
S6 kinase (Thr 389), anti-phospho-S6-ribosomal protein
(Ser 240/244), anti-phospho-p44/p42 MAPK (Thr 202/
Tyr 204), anti-phospho-glycogen synthase kinase 3 beta
(Ser 9), anti-phospho-Akt (Thr 308), anti-phospho-Akt
(Ser 473), anti-LC3B, anti-ATG5, anti-cleaved caspase 3,
and anti-IRS1 were purchased from Cell Signaling Tech-
nology. Anti-actin antibody was purchased from Santa
Cruz Biotechnology. The Alexa FluorW 488 goat anti-
rabbit IgG was purchased from Invitrogen. Anti-rabbit
and anti-mouse secondary antibodies were purchased
from Jackson ImmunoResearch Laboratories.
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Fluorescence analysis of GFP-LC3:
Cells were seeded in six-well plates over which sterile
cover slips had been previously placed. After treatment,
the cells were washed twice with PBS and fixed in a so-
lution of 4 % paraformaldehyde and 0.19 % picric acid in
PBS for 30 min at room temperature, followed by wash-
ing three times with PBS. Finally, slides were mounted
with cover slips and examined under a fluorescence
microscope (Olympus BX51).
Immunofluorescence analysis of endogenous LC3:
Cells were seeded in six-well plates, over which sterile
cover slips had been previously placed. After treatment,
the cells were washed twice with TBS and fixed in a solu-
tion of 4 % paraformaldehyde and 0.19 % picric acid in
PBS for 30 min at room temperature. After washing
three times with TBS, the cells were permeabilized in
digitonin solution (50 μg/ml digitonin in PBS, pH 7.2) for
5 min at 37 °C. The solution was discarded, and excess
digitonin was quenched by incubation in a solution of
50 mM NH4Cl in PBS for 5 min at 37 °C. The cells were
rinsed twice with TBS and incubated in blocking solution
[2 % (w/v) bovine serum albumin and 5 % (v/v) normal
goat serum in TBS] for 30 min at 37 °C. After rinsing
three times in TBS, the cells were incubated in anti-LC3
antibody solution (5 μg/ml anti-LC3 antibody in blocking
solution) for 60 min at 37 °C. The cells were then washed
twice with TBS for 5 min each cycle, and incubated in
0.05 % (v/v) goat anti-rabbit IgG conjugated with
Alexa488 (Invitrogen), in blocking solution for 60 min at
37 °C, followed by washing five times with TBS for 5 min
each wash cycle. Finally, slides were mounted with cover
slips and examined under a fluorescence microscope.
Electron microscopy
The cells to be examined were prefixed in 2 % glutaral-
dehyde in PBS at 4 °C, treated with 1 % OsO4 for 3 h at
4 °C, dehydrated in a series of graded ethanol baths and
flat embedded in EponW epoxy resin. Ultra-thin sections
were doubly stained with uranyl acetate and observed
under an electron microscope (Hitachi H-7650, 60 kV).
Statistical analysis
Continuous data are presented as mean averages with
standard deviations. Comparison of continuous data was
performed by the Student’s T-test or the Mann–Whitney
U test using SPSS for WINDOWS, version 12.0. (Chi-
cago, IL, United States). A p-value of less than 0.05
(two-tailed) was considered significant.
Results
Establishment of NIH/3T3 cells overexpressing functional IRS-1
We chose NIH/3T3 cells as an experimental model to in-
vestigate the role of IRS-1 in oxidative stress-mediatedautophagy and cell death. Western blotting confirmed
the presence of IRS-1 in wild-type NIH/3T3 cells
(Figure 1A). To mimic the increased expression levels of
IRS-1 seen in tumor cells, we established NIH/3T3 cells
with stable overexpression of IRS-1. The levels of total
IRS-1 in both the control NIH/3T3 cells and NIH/3T3
cells overexpressing IRS-1 were checked by Western blot
analysis. The amount of total IRS-1 was greater in cells
infected with retrovirus encoding for the IRS-1 gene than
it was in the control cells (Figure 1B), indicating that ex-
ogenous IRS-1 was expressed in abundant quantities.
Next, we checked if the expressed IRS-1 was functional
by determining whether the well-established downstream
IRS-1 effectors, including p70 ribosomal protein S6 kin-
ase (p70 S6K), Akt, and ERK were affected by the overex-
pression of IRS-1. The extent of phosphorylation of p70
S6K at Thr 389, and S6 proteins (the downstream effec-
tors of p70 S6K) at Ser 240/244 was greater in cells over-
expressing IRS-1 than in the control cells treated with or
without insulin (Figure 1B). Following insulin treatment,
the extent of phosphorylation of Akt at Thr 308 and Ser
473, and the extent of glycogen synthesis kinase 3 beta
(the downstream effector of Akt) at Ser 9, was greater in
the IRS-1 overexpressing cells than it was in the control
cells. In the absence of insulin treatment, there were no
obvious differences in the extent of phosphorylation of
target proteins between the two groups of cells
(Figure 1C). The extent of phosphorylation of ERK1 and
ERK2 at Thr 202 and Tyr 204 was also greater in cells
overexpressing IRS-1 than it was in the control cells
under a steady state growth phase (Figure 1D). Thus, we
successfully established NIH/3T3 cells with stable over-
expression of functional IRS-1 proteins.
Effect of IRS-1 overexpression on basal autophagy
IRS-1 increases the activity of class I PI3K/Akt signaling
and mTOR [31,36], which is located downstream of the
class I PI3K/Akt signaling pathway, and is the core nega-
tive regulator of autophagy. Thus, it is possible that
autophagy is inhibited in NIH/3T3 cells that overexpress
IRS-1. To confirm this hypothesis, we investigated basal
autophagy by following the conversion of LC3B, from
LC3B-I, which is found in the cytosol as a free form, to
LC3B-II via conjugation with phosphatidylethanolamine.
LC3B-II associates with autophagosome membranes,
and its generation is a promising autophagosomal mar-
ker [39,40]; the amount of LC3-II usually correlates
well with the number of autophagosomes [40]. We
compared the induction of autophagy between samples
using the LC3B-II level, rather than the LC3B-II:LC3B-
I ratio, in accord with suggestions in previous report
[41]. We checked cellular levels of LC3B-II during the
exponential growth phase, and at roughly 70–80 %
confluence, and found that LC3B-II levels in the IRS-1
Figure 1 Establishment of NIH/3T3 cells with stable overexpression of functional IRS-1. (A) Wild-type NIH/3T3 cells were serum starved
overnight and then treated with serum free DMEM or with 100 nM insulin in serum free DMEM for 20 min. Endogenous IRS-1 was examined by
Western blotting. (B) Cells selected after infection by the control retrovirus and those encoding for IRS-1were serum starved overnight and then
treated with serum free DMEM or with 100 nM insulin in serum free DMEM for 20 min. The amounts of endogenous and overexpressed IRS-1,
and p70 S6K signaling were determined by Western blotting. We used serum free DMEM to avoid the confounding effects on p70 S6K signaling
by other growth factors that may be present in serum. (C) Cells were serum starved overnight and then treated with serum free DMEM or with
100 nM insulin in serum free DMEM for 20 min. Akt signaling was monitored by Western blotting. Using serum free DMEM avoided the
confounding effects of other growth factors that may be present in serum. (D) Cells were cultured for 18 h before beginning an experiment. The
medium was not changed for the control cell group, but was replaced with fresh complete culture medium for the experimental cell group. The
ERK1/2 signaling pathway was analyzed using Western blot analysis.
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control cells. Further, we counted the number of autop-
hagic vacuoles visible under an electron microscope.
The number of autophagic vacuoles was greater in the
control cells than in the IRS-1 overexpressing cells
(7.3 + 5.1 vs. 3.6 + 3.4, p = 0.002) (Figure 2A). These
results indicate that overexpression of IRS-1 reduces
the number of autophagosomes, and imply that overex-
pression of IRS-1 reduces autophagy.
LC3B-II accumulation can result from increased up-
stream autophagosome formation or from impaired
downstream autophagosome-lysosome fusion. To distin-
guish between these two possible explanations for the
decrease in LC3B-II levels in NIH/3T3 cells that overex-
press IRS-1, we determined the autophagic flux using
LC3 turnover assay in the presence of bafilomycin-A. If
the amount of LC3B-II further accumulates in the pres-
ence of bafilomycin-A, it indicates that autophagic flux
is intact, however, if the LC3B-II levels remain un-
changed, it is likely that the autophagic flux is impaired
[41,42]. Autophagic flux is used to denote the dynamicprocesses of autophagosome synthesis, delivery of autop-
hagic substrates to the lysosome, and degradation of
autophagic substrates within the lysosome, and is a reli-
able indicator of autophagic activity [42]. First, we stud-
ied the nutrient starvation induced autophagy [43] in
both the control cells and the IRS-1 overexpressing cells.
Both groups of cells were seeded and cultured for one
day, then the culture medium was replaced with fresh
DMEM containing 10 % FBS or with Earle’s Balanced
Salt Solution (EBSS), an amino acid deficient solution,
for 6 h. Treatment with EBSS resulted in increased
LC3B-II levels in both the control cells and the IRS-1
overexpressing cells (Figure 2B). The levels of LC3B-II
were greater in the presence of bafilomycin-A than in
the absence of bafilomycin-A for both groups of cells, ei-
ther treated with DMEM containing 10 % FBS or with
EBSS, indicating that the autophagy fluxes were intact in
both groups of cells. We next investigated the effect of
insulin, which inhibits autophagy [31,36], on autophagy
in both the control cells and the IRS-1 overexpressing
cells (Figure 2C). Treatment with 500 nM insulin for 6 h
Figure 2 Effect of IRS-1 overexpression on autophagy. (A) Cells were seeded and cultured for one day. Then, the amounts of LC3B-II
between the IRS-1 overexpressing cells and the control cells were compared by Western blotting (left); the level of LC3B-II was normalized to that
of actin for comparison (right). Autophagic vacuoles (black arrowheads) were observed under an electron microscope (Scale bar = 100 nm), and
were counted in randomly selected groups of 30 cells. (B) Cells seeded and cultured for one day were further incubated in fresh DMEM
containing 10 % FBS, or in EBSS, an amino acid deficient medium, for 6 h in the presence or absence of 100 nM bafilomycin-A. The influence of
amino acid deprivation on autophagy was determined from LC3B-II levels by Western blotting (Left). The levels of LC3B-II in the absence of
bafilomycin-A were normalized to that of actin for comparison (right). (C) Cells seeded and cultured for one day were further incubated in fresh
serum free DMEM with or without 500 nM insulin for 6 h in the presence or absence of 100 nM bafilomycin-A. Using serum free DMEM avoided
the confounding effects on autophagy of other growth factors that may be present in serum. The influence of insulin stimulation on autophagy
was determined from LC3B-II levels using Western blotting (Left); the levels of LC3B-II in the absence of bafilomycin-A were normalized to that of
actin for comparison (right). (D) Cells seeded and cultured for one day were further incubated in fresh DMEM containing 10 % FBS for 6 h in the
presence or absence of 100 nM bafilomycin-A. LC3B-II levels were determined by Western blotting (Left), and the levels of LC3B-II in the absence
of bafilomycin-A were normalized to that of actin for comparison (right). (E) Cells seeded and cultured for one day were further incubated in
fresh DMEM containing 10 % FBS for the indicated time, and LC3B-II levels were examined by Western blotting.
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The levels of LC3B-II were greater in the presence of
bafilomycin-A than in the absence of bafilomycin-A for
both groups of cells either without or with insulin treat-
ment. This finding indicates that the autophagic fluxesremain intact in both the control cells and the IRS-1
overexpressing cells.
We further investigated whether overexpression of
IRS-1 inhibits autophagy in this series of experiments.
During the exponential growth phase, and at roughly
Chan et al. Journal of Biomedical Science 2012, 19:64 Page 7 of 16
http://www.jbiomedsci.com/content/19/1/6470 %-80 % confluence, both groups of cells were treated
with fresh DMEM containing 10 % FBS, in the absence
or presence of bafilomycin-A, for 6 h. As shown in
Figure 2D, in the absence of bafilomycin-A, LC3B-II
levels in the IRS-1 overexpressing cells were lower than
those in the control cells, indicating that there were
fewer autophagosomes in the IRS-1 overexpressing cells.
The levels of LC3B-II were greater in the presence of
bafilomycin-A than in the absence of bafilomycin-A for
both groups of cells, indicating that autophagic fluxes
are intact in both groups of cells. Further, there was a
greater increase in LC3B-II levels between the absence
and presence of bafilomycin-A for the control cells than
there was for the IRS-1 overexpressing cells, indicating
that the autophagic flux was greater in the control cells
than in the cells that overexpress IRS-1 [42]. To confirm
the decrease of LC3B-II in cells overexpressing IRS-1
during the steady state growth phase, we investigated
LC3B-II levels at various times after replacement of the
culture medium. Throughout the 24 h monitoring
period, LC3B-II levels were lower in cells overexpressing
IRS-1 than those were in the control cells (Figure 2E).
Taken together, overexpression of IRS-1 inhibits basal
autophagy during the steady state growth phase.
GO increases intracellular ROS and induces autophagy
We first demonstrated that GO actually increases ROS
in cells. Wild-type NIH/3T3 cells were either treated
with GO (10 mU/ml) or not, and the intracellular ROS
was determined. As shown in Figure 3A, an increase in
intracellular ROS occurred at 6 h, and lasted for at least
24 h following treatment with GO.
We investigated whether increases in ROS induce
autophagy by monitoring changes in LC3B-II levels
in response to GO treatment for the control cells
(Figure 3B) and the IRS-1 overexpressing cells
(Figure 3C). LC3B-II levels in the two groups of
cells increased following treatment with GO (5 and
10 mU/ml) for 6 h. The levels of LC3B-II were greater in
the presence of bafilomycin-A than in the absence of
bafilomycin-A for both the control cells and the IRS-1
overexpressing cells. These results suggest that GO
induces autophagy in both groups of cells.
Electron microscopy was used to examine GO induced
autophagy. During the basal growth state, there were few
autophagic vacuoles present in the cytoplasm (Figure 3D,
1 and 2). The numbers of autophagic vacuoles increased
after 24 h treatment with GO (10 mU/ml) (Figure 3D
and 4). These results indicate that treatment with GO
induces autophagy in NIH/3T3 cells.
We examined the aggregation of GFP-LC3 protein
using fluorescence microscopy, to confirm that GO
induces autophagy. Upon induction of autophagy, LC3
protein is processed, lipidated, and incorporated into theexpanding autophagosome membrane [44]. GFP-LC3
protein is frequently used as an autophagy marker; it
translocates from a mainly cytosolic to a punctuate
localization upon autophagosome accumulation. There
were more green dots in cells treated with GO than
there were in cells not receiving GO treatment, for
both the control cells and the cells overexpressing IRS-1
(Figure 4). Similar results were observed when the aggre-
gation of endogenous LC3 protein was directly stained
with the anti-LC3 antibody and the Alexa488-conjugated
secondary antibody (Figure 5). These results further sup-
port that GO induces autophagy.
IRS-1 reduces oxidative stress-mediated autophagy
We hypothesized that oxidative stress induces autophagy
via inhibition of IRS-1/Akt/mTOR signaling, and that
enhancement of the IRS-1/Akt/mTOR signaling would
reduce oxidative stress-mediated autophagy. We exam-
ined the phosphorylation of p70 S6K at Thr 389 as a
representative of mTOR activity, because p70 S6K is the
main downstream effector of mTOR.
After treatment with GO, LC3B-II levels were
increased and the extent of phosphorylation of p70 S6K
at Thr 389 was reduced in the control cells (Figure 6).
These results confirm that oxidative stress reduces
mTOR activity and induces autophagy. In cells overex-
pressing IRS-1, the influence of GO on LC3B-II levels
and phosphorylation of p70 S6K at Thr 389 was les-
sened. These results suggest that overexpression of IRS-
1 attenuates the inhibition of mTOR/p70 S6K activity
that is induced by treatment with GO, and restores the
ability of mTOR to regulate autophagy.
Effect of IRS-1 on oxidative stress-mediated cell fate
Low levels of ROS promote cell growth, but high levels
induce cell death [13]. We have shown above that IRS-1
reduces oxidative stress mediated-autophagy. Although
autophagy usually serves as a survival mechanism, exces-
sive autophagy may lead to cell death [45,46]. We stud-
ied the effect of IRS-1 on oxidative stress-mediated cell
fate by using the control cells and NIH/3T3 cells overex-
pressing IRS-1 (Figure 7A). The quantity of the reduced
form of alamarBlue, an indicator of cell proliferation,
was greater in cells overexpressing IRS-1 compared to
that in the control cells, indicating that IRS-1 promotes
cell proliferation. In addition, the amount of the reduced
form of alamarBlue was slightly greater in cells treated
with 5 mU/ml GO than that in cells without treatment,
for both the control cells and the IRS-1 overexpressing
cells, indicating that low levels of oxidative stress
(5 mU/ml GO) promoted cell proliferation. However,
high levels of oxidative stress (10 mU/ml GO) resulted
in cell death, manifested by rounding of the cells, and
detachment of the cells from the culture dish.
Figure 3 (See legend on next page.)
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Figure 3 GO treatment increases intracellular ROS and induces autophagy. (A) Wild-type NIH/3T3 cells were treated with 10 mU/ml GO
for various time intervals, and intracellular ROS levels were measured. (B) & (C) Control cells and cells overexpressing IRS-1 were treated with
5 or 10 mU/ml of GO for 6 h. LC3B-II levels were determined by Western blotting (left), and the levels of LC3B-II were normalized to that of
actin for comparison (right) (upper two panels). Bafilomycin-A (100 nM) was added to determine the autophagic flux integrity (bottom
panels). (D) Wild-type NIH/3T3 cells without (1,2) or with (3,4) treatment of 10 mU/ml GO for 24 h were examined under an electron
microscope. Black arrowheads indicate autophagic vacuoles accumulated in cytoplasm.
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ologies of cells that perished due to high ROS levels.
Wild-type NIH/3T3 cells were treated with 10 mU/ml
GO for 24 h. All cells, whether floating in the medium,
or attached to the culture dish, were collected and pre-
pared for electron microscopy. As shown in Figure 7B-1,
the cells manifested characteristics of necrosis, including
swollen cells and mitochondria, disruption of the cellular
membrane, and cell lysis [47]. Autophagic vacuoles had
accumulated in the dying cells (Figure 7B-2), indicating
that oxidative stress-mediated cell death is accompanied
by induction of autophagy. We further compared the ex-
tent of cell death caused by ROS for the control cells
and the IRS-1 overexpressing cells. The control cells,
and cells overexpressing IRS-1, were treated with 5 and
10 mU/ml GO for 6 h. Cells were collected by trypsini-
zation and stained with trypan blue. The proportion of
cell death was similar for both groups of cells during the
basal growth state. GO treatment at 5 mU/ml did not
result in cell death; however, cell death ensued from GO
treatment at 10 mU/ml, with a lower percentage of mor-
tality in cells overexpressing IRS-1 than that seen for the
controls (Figure 7C). We used flow cytometry assay to
confirm that IRS-1 provides protection against cell deathFigure 4 GO treatment induces autophagy. Cells expressing GFP-LC3 ge
(lower half) were treated with 10 mU/ml GO or vehicle (DMSO) for 6 h, andcaused by oxidative stress [48]. The control cells and the
IRS-1 overexpressing cells were treated with 10 mU/ml
GO for 6 h. The cells were collected using trypsinization
and stained with PI for flow cytometry analysis [48]. The
high levels of oxidative stress induced less cell death in
cells overexpressing IRS-1 than it did in the control cells
(Figure 7D). Taken together, overexpression of IRS-1
promotes cell growth and reduces oxidative stress
mediated-cell death.
Oxidative stress induces autophagy-dependent cell death
Our electron microscopy observations of cell death
confirmed that oxidative stress induces cell necrosis.
However, the manifestations of cell morphologies char-
acteristic of cell necrosis suggest necrotic cell death,
apoptotic cell death with secondary necrosis, or autop-
hagic cell death. Oxidative stress induces autophagy,
and excess autophagy causes cell death [45,46]; cell
death caused by GO treatment is accompanied by induc-
tion of autophagy (Figure 7B-2). Thus, we wondered
whether oxidative stress induces autophagy-dependent
or autophagic cell death in the NIH/3T3 cells used in this
study. To answer this question, we investigated whether
inhibition of autophagy by knockdown of ATG-nerated using the controls (upper half) and cells overexpressing IRS-1
observed under a fluorescence microscope.
Figure 5 GO treatment induces autophagy. Control cells (upper half) and cells overexpressing IRS-1 (lower half) were treated with 10 mU/ml
GO or vehicle (DMSO) for 6 h, stained with anti-LC3B antibody and goat anti-rabbit IgG conjugated with Alexa488, and observed under a
fluorescence microscope.
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determining autophagic cell death [49]. Wild-type NIH/
3T3 cells were infected with lentivirus containing an in-
sert encoding shRNA for ATG-5, to establish stable
NIH/3T3 cell lines with knockdown of ATG-5. As
shown in Figure 8A, ATG-5 levels were reduced in the
two stable cell lines, and the levels of LC3B-II, an indica-
tor of autophagy induction, were reduced by roughly
75 % in both the two stable cell lines. These results con-
firm that knockdown of ATG-5 was successful andFigure 6 IRS-1 reduces the oxidative stress-mediated autophagy. Con
(DMSO) or 10 mU/ml GO for 6 h. Changes in the extent of phosphorylation
blotting (left). The levels of phosphorylated p70 S6K and LC3B-II were normautophagy was reduced in these knockdown cells. The
control cells and the ATG-5 knockdown cells were trea-
ted with 10 mU/ml GO for 6 h. As anticipated, the treat-
ment resulted in increased LC3B-II levels in the control
cells, and this effect was reversed in the ATG-5 knock-
down cells (Figure 8B). Cell death following treatment
with 10 mU/ml GO for 6 h was analyzed by trypan blue
dye exclusion assay and flow cytometry. The proportion
of cell death was similar for both the control cells and
the ATG-5 knockdown cells during the basal growthtrol cells and cells overexpressing IRS-1 were treated with vehicle
of p70 S6K at Thr 389 and in LC3B-II levels were analyzed by Western
alized to that of actin for comparison (right).
Figure 7 Effect of IRS-1 on oxidative stress-mediated cell fate. (A) Control cells and cells overexpressing IRS-1 were treated with 5 mU/ml
GO for 9 h. Cell proliferation was measured using alamarBlue assay. (B) Wild-type NIH/3T3 cells were treated with 10 mU/ml GO for 24 h. Dead
cells were observed using an electron microscope. The scale bar in panel B-2 represents 2 μm, and in B-b, represents 500 nm. Black arrowheads
indicate autophagic vacuoles. (C) Control cells and cells overexpressing IRS-1 were treated with 5 or 10 mU/ml GO for 6 h. Cells were collected
by trypsinization and stained with trypan blue. Dead cells were observed and counted under a light microscope. Three dishes of cells of each
condition were observed for statistical analysis. Results from a representative of three independent experiments are shown. (D) Control cells and
cells overexpressing IRS-1 were treated with 10 mU/ml GO for 6 h. Cells were collected by trypsinization and stained with PI. Cell death was
analyzed from the proportion of sub-G1 group DNA determined by flow cytometry analysis. Four independent experiments were performed for
statistical analysis. M1 indicates the sub-G1 DNA area.
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Figure 8 Oxidative stress induces autophagy-dependent cell death. (A) Two stable ATG-5 knockdown cell lines were examined for the
presence of ATG-5 by Western blotting (left). The levels of ATG-5 and LC3B-II were normalized to that of actin for comparison over four
independent experiments (right). (B) Control cells and the ATG-5 knockdown cells were treated with DMSO or GO for 6 h. ATG-5, LC3B-I, and
LC3B-II levels were examined by Western blotting (left). The levels of LC3B-II were normalized to that of actin for comparison, using three
independent experiments (right). (C) Control cells and the ATG-5 knockdown cells were treated with 10 mU/ml GO for 6 h. Cell death was
examined using trypan blue dye exclusion assay. Three dishes of cells of each condition were observed for statistical analysis. The results for a
representative sample of three independent experiments are shown. (D) Control cells and the ATG-5 knockdown cells were treated with 10 mU/
ml GO for 6 h. Cells were collected using trypsinization and stained with PI. Cell death was analyzed from the proportional area of sub-G1 group
DNA, as determined by flow cytometry. Eight independent experiments were performed for statistical analysis. M1 indicates the sub-G1 area.
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seen for the ATG-5 knockdown cells than that for the
control cells, following treatment with 10 mU/ml GO for6 h (Figure 8C). Flow cytometry analysis showed no differ-
ences in the sub-G1 peak between the control cells and
the ATG-5 knockdown cells in the absence of GO
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GO, the sub-G1 peak area was less in the ATG-5 knock-
down cells than it was in the controls (Figure 8D). Taken
together, these results indicate that autophagy induction
by oxidative stress does not protect cells from death, and
that oxidative stress induces autophagy-dependent or
autophagic cell death.
Discussion
The current study shows that overexpression of IRS-1
promotes cells growth, inhibits basal autophagy, reduces
oxidative stress-induced autophagy, and diminishes oxi-
dative stress-mediated autophagy-dependent cell death.
We have provided evidence that ROS induces autophagy
via inhibition of IRS-1/PI3K/mTOR signaling.
We found that low levels of ROS promote cell prolif-
eration (Figure 7A), while high levels induce cell death,
in agreement with previous reports [13]. We found that
the flow cytometry sub-G1 peak area increased in the
DNA histogram (Figure 7D, Figure 8D), indicating that
ROS induces apoptosis, and that GO generated ROS
induced autophagy (Figure 3B-D, Figure 4, Figure 5).
Oxidative stress-induced autophagy did not protect cells
from death; inhibition of autophagy by knockdown of
ATG-5 reduced cell death caused by oxidative stress
(Figure 8C-D). These data suggest that oxidative stress
induces autophagy-dependent or autophagic cell death.
Autophagy has been proposed to kill the cells directly,
and to participate in a lethal signaling event activating
an apoptotic or necrotic death pathway [50]. Our data is
consentient with other reports [51-53] supporting the
notion that “autophagic cell death” does occur, although
it is often thought to be a misnomer [47]. Indeed, there
are numerous reports suggesting that autophagy is a sur-
vival mechanism that protects cells in response to envir-
onmental stresses. In human and mouse cells, deletion
of autophagy-related genes generally fails to confer pro-
tection against the induction of cell death by stressors,
and rather accelerates cell death [54,55]. Additionally,
the observation that chemicals with the ability to inhibit
autophagy significantly accelerate cellular necrosis fur-
ther supports the idea that autophagy acts primarily as a
cytoprotective, rather than cytotoxic process [56]. In
summary, oxidative stress can cause necrotic, apoptotic,
and autophagic cell death.
Our observation of reduced phosphorylation of p70
S6K, a major downstream effector of mTOR, in response
to GO treatment indicates that oxidative stress reduces
mTOR activity (Figure 6). Additionally, overexpression
of IRS-1 attenuates the inhibitory effect of oxidative
stress on mTOR/p70 S6K signaling (Figure 6). These
results suggest that overexpression of IRS-1 competes
with the inhibitory signal mediated by oxidative stress
on mTOR. Importantly, the oxidative stress mediatedinduction of autophagy was attenuated by overexpres-
sion of IRS-1 (Figure 6). Taken together, these findings
suggest that inhibition of IRS-1/PI3K/Akt/mTOR sig-
naling is another mechanism for oxidative stress-
induced autophagy.
We demonstrated that overexpression of IRS-1 inhibits
autophagy in the present study. The previous finding in-
dicating that knockout of IRS-1 results in increased
numbers of autophagosomes in mice cardiomyocytes
[57] further supports our data, and suggests that IRS-1 is
involved in the regulation of autophagy. We found that
overexpression of IRS-1 increases both ERK and mTOR/
p70 S6K activity (Figure 1B, Figure 1D). Activation of
ERK signaling induces autophagy [58], activation of
mTOR signaling inhibits autophagy [29], and activation
of p70 S6K signaling induces autophagy [59,60]. Basal
autophagy was decreased in cells overexpressing IRS-1
(Figure 2) even though ERK and p70 S6K signaling were
activated. This might be due to the interaction of com-
plex intracellular signaling networks in response to dif-
ferent stimuli, and be explained by the presence of
different downstream mTOR signaling pathways. The
mTOR/p70 S6K signaling is involved in cell growth, thus,
cells overexpressing IRS-1 grow more rapidly than the
control cells do (Figure 7A). However, the mTOR/
unc-51-like kinase (ULK) signaling negatively regulates
autophagy [31]. In summary, mTOR is activated by
overexpression of IRS-1 in cells, in which autophagy
is inhibited.
Despite its lack of intrinsic kinase properties, IRS-1 is
thought to be involved in tumorigenesis, it interacts with
β-catenin, an important regulator of stem/progenitor cell
fate, and levels of β-catenin target genes, such as c-myc
and cyclin D1, are increased in mammary tumors that
overexpress IRS-1 [61]. IRS-1 directly binds, interacts, and
cooperates with numerous oncogene proteins, including
JCV T antigen [62], and simian virus 40 T antigen [63].
Additionally, IRS-1 has an anti-apoptotic function that
protects cells from apoptotic cell death [64,65]. In this
study, we found that activation of IRS-1 signaling pro-
motes cell proliferation (Figure 7A), probably via concomi-
tant activation of mTOR/p70 S6K and ERK signaling
(Figure 1B & D). Both of these pathways are involved in
cell growth and proliferation [4]. Further, IRS-1 protects
cells from oxidative stress-mediated cell death (Figure 7C,
D). These may be the reasons why the expression levels of
IRS-1 increase in some types of cancers. Thus, our find-
ings afford a credible explanation for IRS-1 involvement
in the tumor initiation and progression.
The proposed relationship between IRS-1, oxidative
stress, and regulation of autophagy and cell growth is
shown in Figure 9. In addition to activating p70 S6K to
promote cell growth, mTOR negatively regulates autop-
hagy via inhibition of the ULK complex. IRS-1 promotes
Figure 9 The interaction between IRS-1 and oxidative stress in
the regulation of autophagy and cell growth. The reported
signaling pathways and the results presented in this study are
summarized.
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activity; it also promotes cell proliferation via activation
of ERK signaling. ROS activates AMPK by activating
ATM protein, or via other pathways; AMPK then pro-
motes autophagy through direct inhibition of mTOR, or
by indirect inhibition of IRS-1/Akt/mTOR signaling. By
contrast, IRS-1 can reduce AMPK activity by inhibition
of LKB1. Both the ERK [58] and p70 S6K [59,60] signal-
ing can induce autophagy.Conclusion
Our results imply that IRS-1 plays a poorly defined but
important role in the pathogenesis of human diseases
that exhibit abnormal proliferation of cells, such as can-
cers, benign prostate hyperplasia, and atherosclerotic
coronary artery disease. This is because IRS-1 can pro-
mote cell proliferation and help cells to resist the oxida-
tive stresses generated during cell proliferation. Further
investigation into the role of the IRS-1 protein in spe-
cific human diseases that feature increased expression
levels of IRS-1 would be worthwhile. Genetic or
pharmacologic intervention to inhibit IRS-1 signaling
might be an effective strategy to treat diseases character-
ized by uncontrolled proliferation of cells.Abbreviations
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